KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rigel Pharmaceuticals (RIGL) Assets Average (2016 - 2025)

Historic Assets Average for Rigel Pharmaceuticals (RIGL) over the last 15 years, with Q3 2025 value amounting to $224.6 million.

  • Rigel Pharmaceuticals' Assets Average rose 6774.63% to $224.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $224.6 million, marking a year-over-year increase of 6774.63%. This contributed to the annual value of $140.6 million for FY2024, which is 1180.78% up from last year.
  • As of Q3 2025, Rigel Pharmaceuticals' Assets Average stood at $224.6 million, which was up 6774.63% from $191.4 million recorded in Q2 2025.
  • Over the past 5 years, Rigel Pharmaceuticals' Assets Average peaked at $224.6 million during Q3 2025, and registered a low of $116.2 million during Q3 2023.
  • In the last 5 years, Rigel Pharmaceuticals' Assets Average had a median value of $138.5 million in 2022 and averaged $152.1 million.
  • Per our database at Business Quant, Rigel Pharmaceuticals' Assets Average crashed by 3723.27% in 2022 and then skyrocketed by 6774.63% in 2025.
  • Quarter analysis of 5 years shows Rigel Pharmaceuticals' Assets Average stood at $176.9 million in 2021, then fell by 29.38% to $124.9 million in 2022, then dropped by 6.94% to $116.3 million in 2023, then surged by 30.46% to $151.7 million in 2024, then skyrocketed by 48.08% to $224.6 million in 2025.
  • Its Assets Average was $224.6 million in Q3 2025, compared to $191.4 million in Q2 2025 and $170.0 million in Q1 2025.